Clinical Trials Browser

INDUSTRY × Glioblastoma × Everolimus × Clear all

NCT00107237 2013-06-12

AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

Phase 1/2 Completed

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00515086 2011-09-22

Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)

Phase 2 Terminated

41 enrolled 11 charts

Dyschromatosis symmetrica hereditaria 1, Glioblastoma